RBR-29x2pr招募中1 期
The use of human stem cells for the treatment of stress urinary incontinence in women.
niversidade Federal de São Paulo0 个研究点开始时间: 2019年5月7日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 性别
- Female
入选标准
- •Inclusion criteria.
- •1. Patients with moderate primary and refractory stress urinary incontinence confirmed by stress cough test; or during urodynamic study; or during the pad test.
排除标准
- •Exclusion Criteria
- •Patients with prolapse of anterior or uterine vaginal wall greater than stage 2 POP-Q;
- •Patients submitted to surgical procedures to repair previous SUI;
- •Patients with genital malformations that make it impossible to inject at the site of
- •middle third of the urethra;
- •Patients submitted to previous pelvic radiotherapy;
- •Patients who during clinical evaluation or urodynamics present other
- •diagnoses that not only SUI;
- •Patients who did not agree to participate in the study at any stage or the ones who are not able to read, write and understand the study;
- •Patients <18 years of age.
研究者
相似试验
撤回
不适用
Application of mesenchymal stem cells in patients with end-stage renal diseaseNL-OMON34665Erasmus MC, Universitair Medisch Centrum Rotterdam16
已完成
3 期
Adult Human Mesenchymal Stem Cells for the treatment of Steroid-Refractory Acute Graft-versus-Host DiseaseGraft-versus-host reaction or disease.Graft-versus-host reaction or diseaseIRCT2014072618603N1Vice chancellor of research, Shiaz Univeisity of Medical Sciences20
进行中(未招募)
1 期
Infusion of mesenchymal stem cells as treatment for steroid resistant grade II to IV acute GVHD or poor graft function: a multicenter phase II studyEUCTR2007-004310-14-BECHU-ULG120
撤回
2 期
Infusion of mesenchymal stem cells as treatment for steroid resistant grade II to IV acute GVHD or poor graft function: a multicenter phase II studymesenchymale stamcellen bij acute GvHD of onvoldoende functionerende greffeacute GvHD1002432410018865rejectionNL-OMON31471Academisch Ziekenhuis Maastricht10
进行中(未招募)
1 期
Clinical research using the mesenchymal stem cells from autologous fat tissue of Alzheimer dementiaJPRN-jRCTb050190035OOYAMA TAKAYUKI3
